ABERRANT SPLICING OF A BRAIN-ENRICHED ALTERNATIVE EXON ELIMINATES TUMOR SUPPRESSOR FUNCTION AND PROMOTES ONCOGENE FUNCTION DURING BRAIN TUMORIGENESIS.

MLA

Bredel, Markus, et al. “Aberrant Splicing of a Brain-Enriched Alternative Exon Eliminates Tumor Suppressor Function and Promotes Oncogene Function during Brain Tumorigenesis.” Neuro-Oncology, vol. 16, no. suppl_3, July 2014, pp. iii19-iii20. EBSCOhost, https://doi.org/10.1093/neuonc/nou206.71.

APA

Bredel, M., Ferrarese, R., Harsh, G. R., Yadav, A. K., Bug, E., Maticzka, D., Reichardt, W., Masilamani, A. P., Dai, F., Kim, H., Hadler, M., Scholtens, D. M., Yu, I. L. Y., Beck, J., Srinivasasainagendra, V., Costa, F., Baxan, N., Pfeifer, D., Elverfeldt, D. v., & Backofen, R. (2014). Aberrant Splicing of a Brain-Enriched Alternative Exon Eliminates Tumor Suppressor Function and Promotes Oncogene Function during Brain Tumorigenesis. Neuro-Oncology, 16(suppl_3), iii19-iii20. https://doi.org/10.1093/neuonc/nou206.71

Chicago

Bredel, Markus, Roberto Ferrarese, Griffith R. Harsh, Ajay K. Yadav, Eva Bug, Daniel Maticzka, Wilfried Reichardt, et al. 2014. “Aberrant Splicing of a Brain-Enriched Alternative Exon Eliminates Tumor Suppressor Function and Promotes Oncogene Function during Brain Tumorigenesis.” Neuro-Oncology 16 (suppl_3): iii19-iii20. doi:10.1093/neuonc/nou206.71.